PROCTER & GAMBLE Co (PG) Stock News

A class action lawsuit has been filed against GPGI, Inc. in the U.S. District Court for the Southern District of New York on behalf of investors who purchased GPGI Class A common stock between November 3, 2025 and May 6, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding the overstatement of Husky's value, failure to disclose that Husky was not on track to meet revenue and EBITDA targets, and that the acquisition was primarily motivated by generating fees rather than creating shareholder value.

Rosen Law Firm has filed class action lawsuits against GPGI, Inc. (formerly CompoSecure), Lucid Group, Inc., and Nano-X Imaging Ltd. on behalf of investors who suffered losses. The GPGI lawsuit alleges defendants made materially false statements regarding the Husky acquisition valuation and financial targets. Investors are encouraged to secure counsel before important deadlines.

IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million plus up to €50 million in earnout consideration. The acquisition aims to create a scaled medical laser platform combining IPG's urology expertise with Lumibird Medical's ophthalmology leadership, expected to add approximately $1 billion in addressable market and be accretive to gross margin, EBITDA, and adjusted EPS. The transaction is expected to close in Q4 2026.

A securities class action lawsuit has been filed against GPGI, Inc. on behalf of investors who purchased Class A common stock between November 3, 2025 and May 6, 2026. The lawsuit alleges the company made materially false and misleading statements regarding business operations, growth prospects, and financial stability, causing the stock to trade at artificially inflated prices. Investors suffered significant losses when the truth was disclosed.

A class action lawsuit has been filed against GPGI, Inc. (formerly CompoSecure) alleging that company executives and directors made false statements regarding the Husky Technologies acquisition. The lawsuit claims defendants overstated Husky's value and revenue targets, and that the acquisition was primarily motivated by generating fees rather than shareholder value. Following disappointing earnings reports in March and May 2026, GPGI stock fell significantly, with investors eligible to seek lead plaintiff status by September 14, 2026.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.

Robbins Geller Rudman & Dowd LLP has launched an investigation into potential securities law violations by GPGI, Inc. The investigation was triggered after GPGI reported disappointing Q1 2026 results on May 7, 2026, with its Husky segment's Pro Forma Adjusted Net Sales declining 5.2% year-over-year to $290.8 million and Pro Forma Adjusted EBITDA falling 40.2% to $38 million. The stock price subsequently fell nearly 26% on the news.

IPG announced the launch of its new PCR Air Pillow Film, a protective packaging solution containing 50% recycled content (35% post-consumer and 15% post-industrial). The film is compatible with existing IPG inflation machinery and manufactured at a TRUE Zero Waste certified facility, enabling customers to meet sustainability goals without operational changes.

Law firm Robbins Geller Rudman & Dowd LLP is investigating potential securities law violations by GPGI, Inc. following the company's May 2026 earnings report that revealed a significant decline in its Husky segment's sales and EBITDA, resulting in a 26% stock price drop. The firm is seeking investors and witnesses with information about the case.

Opus Genetics announced successful FDA alignment on its Phase 3 clinical trial design for OPGx-LCA5, a gene therapy for LCA5-associated inherited retinal disease. The FDA indicated the company may submit a Biologics License Application based on 6-month efficacy data, with 12-month durability data provided during review. Phase 3 dosing is expected to begin in Q4 2026, with seven of eight planned participants already enrolled.

IPG Photonics director Agnes Tang sold 1,511 shares worth $178,000 under a pre-established Rule 10b5-1 plan, a routine transaction coordinated with other insider selling plans. The real concern for investors is the company's heavy dependence on EV and battery manufacturing demand for growth, while its Advanced Solutions segment shrank year-over-year. Profitability declined due to patent settlements and tariff costs that have reduced gross margins by 150 basis points, creating structural headwinds that could pressure the stock if EV demand cools.

Investor rights law firm Halper Sadeh LLC is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting competing offers.

Changes to the PGA Tour are designed to elevate competition and raise payouts for winners.

India's LPG imports from US set to cross 1 million tons in June, sources say  Reuters

Brodsky & Smith law firm has announced investigations into multiple merger transactions, including Apogee Therapeutics (acquired by AbbVie for $135.11/share), Roku (acquired by Fox for $160/share), TruBridge (acquired by Inventurus for $26.25/share), and Organon (acquired by Sun Pharmaceutical for $14/share). The investigations focus on whether the respective boards breached fiduciary duties by failing to conduct fair processes and whether deal consideration provides fair value to shareholders.

The article compares two global stock ETFs: SPGM (State Street SPDR Portfolio MSCI Global Stock Market ETF) and IEFA (iShares Core MSCI EAFE ETF). SPGM offers broader global exposure including U.S. and emerging markets with superior 5-year returns (28.04% vs 21.55%), while IEFA focuses on developed international markets with a lower expense ratio (0.07% vs 0.09%) and higher dividend yield (3.24% vs 1.67%). The recommendation favors IEFA for investors already holding U.S. equities, citing better diversification and income potential.

Indian refiners bolster crude, LPG supplies despite Iran conflict  Reuters

Ascentage Pharma presented clinical data on alrizomadlin (APG-115), an MDM2-p53 inhibitor, for treating pediatric solid tumors at ASCO 2026. The drug showed preliminary antitumor activity with manageable safety profiles as monotherapy and in combination with lisaftoclax, achieving a 23.5% objective response rate in the combination arm. Alrizomadlin was included in China's SPARK Plan for pediatric oncology development.

Vishay Precision Group (VPG) reported fiscal 2026 first quarter results with year-over-year and sequential revenue growth, along with bookings of $102.1 million, a 29% sequential increase. The company also announced that CFO William M. Clancy will retire effective December 31, 2026.

PG&E Corporation declared its second quarter 2026 regular cash dividend of $0.05 per share on common stock, payable July 15, 2026. The company also declared preferred stock dividends across eight series, payable August 15, 2026. PG&E serves 16 million Californians across Northern and Central California.

Terra Innovatum announced a supply agreement with SPG Dry Cooling for an Air-Cooled Condenser to support the first-of-a-kind deployment of its SOLO™ micro-modular reactor. The water-independent cooling solution expands deployment flexibility across water-constrained and remote environments, supporting the company's transition to scalable commercialization and global market expansion.

The Schwab Emerging Markets Equity ETF (SCHE) offers a lower expense ratio (0.07%) and higher dividend yield (2.60%) compared to State Street's SPDR Portfolio MSCI Global Stock Market ETF (SPGM at 0.09% and 1.70%). However, SPGM has delivered superior 5-year returns ($1,775 vs $1,373 on $1,000 invested) with lower volatility. SCHE focuses exclusively on emerging markets with significant China exposure (31%), while SPGM provides broader global diversification including 62% U.S. exposure, making it better suited as a core portfolio holding.

The global industrial laser market is projected to grow from $7.8 billion in 2025 to $10.94 billion by 2031 at a CAGR of 5.80%. Medium power lasers and CO₂ lasers lead the market, with cutting applications dominating. The semiconductor and electronics sector shows the fastest growth at 7.14% CAGR. APAC retains 53% market share, while India is expected to register the highest regional CAGR. Key trends include integration with quality control systems, visible-wavelength lasers for copper applications, and automation-ready platforms. Market restraints include capital cycle sensitivity and pricing pressure in mature segments.

Old National Bank announced the launch of Team Old National, a golf ambassadors program featuring PGA TOUR player Michael Brennan and top-ranked amateur golfer Kiara Romero. The initiative aims to enhance the bank's visibility through professional and amateur golf tournaments throughout the 2026 season, building on the bank's existing partnerships in golf including its role as official banking partner of Hazeltine National Golf Club.

A consortium led by TPG Inc. has signed a formal agreement to buy India’s top shadow lender specializing in green financing, underscoring foreign investors’ appetite for the country’s fast-growing environmental projects.